Robert John Simes

18PUBLICATIONS
92CO-AUTHORS
Molecular targetsPredictive and prognostic markersTumour immunologyCancer diagnosisHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jul 10, 2026
Enhancing Outcome Measurement in Oncology Clinical Trials Through Artificial Intelligence: A Scoping Review.

|Jul 06, 2026
Time to Treatment Failure as an End Point in Pragmatic Oncology Trials: Association With Progression-Free Survival Across Randomized Studies.

|Jun 16, 2026
Time-to-progression ratio as a potential study endpoint in early-phase oncology trials: pooled analysis of phase II trials from the Australian MoST program.

|Apr 28, 2026
Heterogeneity of treatment effect? What baseline prognostic factors tell us about immunotherapy benefit.

|Feb 18, 2026
Time to achieve response and depth of maximal tumor response as potential surrogates for overall survival in advanced non-small cell lung cancer.

Rachel Woodford, Sally Lord, Tom John

|Feb 13, 2026
Exceptional Response to Durvalumab and Tremelimumab in Pancreatic Acinar Cell Carcinoma With Ultramutated Phenotype Associated With a DNA Polymerase-ε Mutation.

Benjamin Koh, Subotheni Thavaneswaran, Frank Lin

Pageof 3

Frequent Collaborators

6 joint publications

Frank Po-Yen Lin

5 joint publications

Chee Khoon Lee

4 joint publications

Ian Marschner

4 joint publications

Rachel Woodford